Synthesis and biological evaluation of 3,4-diaryloxazolones: A new class of orally active cyclooxygenase-2 inhibitors.
Puig C, Crespo MI, Godessart N, Feixas J, Ibarzo J, Jiménez JM, Soca L, Cardelús I, Heredia A, Miralpeix M, Puig J, Beleta J, Huerta JM, López M, Segarra V, Ryder H, Palacios JM.
Puig C, et al. Among authors: puig j.
J Med Chem. 2000 Jan 27;43(2):214-23. doi: 10.1021/jm991106b.
J Med Chem. 2000.
PMID: 10649977